SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)

Navarro, Miguel; Porras, Ignacio; Hernando, Jorge; Maurente Oliveira, Eduardo; Jimenez Fonseca, Paula; Martinez-Trufero, Javier; Rubió-Casadevall, Jordi

dc.contributor	Vall d'Hebron Barcelona Hospital Campus
dc.contributor.author	Navarro, Miguel
dc.contributor.author	Porras, Ignacio
dc.contributor.author	Hernando, Jorge
dc.contributor.author	Maurente Oliveira, Eduardo
dc.contributor.author	Jimenez Fonseca, Paula
dc.contributor.author	Martinez-Trufero, Javier
dc.contributor.author	Rubió-Casadevall, Jordi
dc.date.accessioned	2024-10-31T12:03:44Z
dc.date.available	2024-10-31T12:03:44Z
dc.date.issued	2024-11
dc.identifier.citation	Alonso-Gordoa T, Jimenez-Fonseca P, Martinez-Trufero J, Navarro M, Porras I, Rubió-Casadevall J, et al. SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023). Clin Transl Oncol. 2024 Nov;26:2902–16.
dc.identifier.issn	1699-3055
dc.identifier.uri	https://hdl.handle.net/11351/12167
dc.description	Thyroid carcinoma; Molecular alterations; Systemic treatment
dc.description.abstract	Thyroid cancer (TC) represents 3% of global cancer incidence. Recent changes have optimized treatment decisions based on risk assessment, molecular profiling, and imaging assessment, leading the development of targeted agents that have modified the natural history of this disease. This increasing complexity on treatment options requires careful assessment at the different stages of the disease to provide the most suitable approach from diagnosis to long-term follow-up. This guideline aims to offer a comprehensive and practical overview on the current status and last updates of TC management.
dc.language.iso	eng
dc.publisher	Springer
dc.relation.ispartofseries	Clinical and Translational Oncology;26
dc.rights	Attribution 4.0 International
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/
dc.source	Scientia
dc.subject	Tiroide - Càncer - Tractament
dc.subject	Tiroide - Càncer - Diagnòstic
dc.subject.mesh	Thyroid Neoplasms
dc.subject.mesh	/therapy
dc.subject.mesh	Practice Guidelines as Topic
dc.title	SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023)
dc.type	info:eu-repo/semantics/article
dc.identifier.doi	10.1007/s12094-024-03736-6
dc.subject.decs	neoplasias de la tiroides
dc.subject.decs	/terapia
dc.subject.decs	guías de práctica clínica como asunto
dc.relation.publishversion	https://doi.org/10.1007/s12094-024-03736-6
dc.type.version	info:eu-repo/semantics/publishedVersion
dc.audience	Professionals
dc.contributor.organismes	Institut Català de la Salut
dc.contributor.authoraffiliation	[Alonso Gordoa T] Medical Oncology Department, Hospital Universitario Ramón y Cajal, Madrid, Spain. [Jimenez Fonseca P] Medical Oncology Department, Hospital Universitario Central de Asturias, ISPA, Oviedo, Spain. [Martinez Trufero J] Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain. [Navarro M] Medical Oncology Department, Complejo Asistencial Universitario de Salamanca. IBSAL, Salamanca, Spain. [Porras I] Medical Oncology Department, Hospital Universitario Reina Sofía, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Córdoba, Spain. [Rubió Casadevall J] Medical Oncology Department, Catalan Institute of Oncology of Girona, Hospital Josep Trueta. ONCOGIRPRO Group, Girona Biomedical Research Institute (IDIBGI), Girona, Spain. [Hernando J] Medical Oncology Department, Gastrointestinal and Endocrine Tumor Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid	39325263
dc.identifier.wos	001324609600001
dc.rights.accessrights	info:eu-repo/semantics/openAccess